TIAA CREF INVESTMENT MANAGEMENT LLC - EPIZYME INC ownership

EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 94 filers reported holding EPIZYME INC in Q4 2016. The put-call ratio across all filers is 3.03 and the average weighting 0.4%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of EPIZYME INC
ValueSharesWeighting
Q1 2019$1,263,000
+105.4%
101,959
+2.0%
0.00%
Q4 2018$615,000
-71.2%
99,917
-50.5%
0.00%
-100.0%
Q3 2018$2,138,000
-5.1%
201,736
+21.4%
0.00%
-50.0%
Q2 2018$2,252,000
+14.4%
166,208
+49.8%
0.00%
+100.0%
Q1 2018$1,969,000
+39.1%
110,943
-1.7%
0.00%0.0%
Q4 2017$1,416,000
-32.4%
112,844
+2.6%
0.00%0.0%
Q3 2017$2,096,000
-6.5%
110,012
-25.9%
0.00%
-50.0%
Q2 2017$2,242,000
+21.1%
148,487
+37.5%
0.00%
+100.0%
Q1 2017$1,851,000
+33.5%
107,952
-5.7%
0.00%0.0%
Q4 2016$1,386,000
+11.0%
114,510
-9.8%
0.00%0.0%
Q3 2016$1,249,000
-6.2%
126,977
-2.4%
0.00%0.0%
Q2 2016$1,332,000
-5.3%
130,033
+12.0%
0.00%0.0%
Q1 2016$1,407,000
-8.5%
116,128
+21.0%
0.00%0.0%
Q4 2015$1,538,000
+24.5%
96,0040.0%0.00%0.0%
Q3 2015$1,235,000
-48.3%
96,004
-3.5%
0.00%
-50.0%
Q2 2015$2,387,000
+174.7%
99,473
+115.0%
0.00%
+100.0%
Q1 2015$869,000
-0.5%
46,2600.0%0.00%0.0%
Q4 2014$873,000
-33.2%
46,260
-4.0%
0.00%0.0%
Q3 2014$1,306,000
-12.9%
48,1720.0%0.00%0.0%
Q2 2014$1,499,000
+189.9%
48,172
+112.0%
0.00%
Q1 2014$517,000
+4.9%
22,724
-4.1%
0.00%
Q4 2013$493,000
-48.2%
23,7040.0%0.00%
-100.0%
Q3 2013$951,000
+44.7%
23,704
+1.4%
0.00%0.0%
Q2 2013$657,00023,3700.00%
Other shareholders
EPIZYME INC shareholders Q4 2016
NameSharesValueWeighting ↓
RP Management, LLC 31,833,334$47,750,00019.42%
MPM BioImpact LLC 3,425,202$3,939,0001.06%
Palo Alto Investors LP 6,774,541$7,791,0000.60%
Foresite Capital Management I, LLC 143,759$165,0000.29%
PLATINUM INVESTMENT MANAGEMENT LTD 6,603,870$7,594,0000.23%
Rock Springs Capital Management LP 7,267,696$8,358,0000.21%
BP PLC 24,687$28,0000.16%
NewGen Asset Management Ltd 250,000$288,0000.13%
GSA CAPITAL PARTNERS LLP 467,836$538,0000.07%
Frazier Life Sciences Management, L.P. 739,369$850,0000.07%
View complete list of EPIZYME INC shareholders